magnitud balanc
ko report larg topline/ep beat highlight
sizeabl declin april volum impact
expect top-line result bottom
path top-line recoveri still uncertain
time magnitud henc remain equal-weight
larg april soft ko report larg top-line ep beat
ko forward commentari wors market expect highlight
point unit case declin april date consist
fear mid-march downgrad stock/beverag group
consensu materi underestim potenti revenu weak
sympathet notion outsiz recoveri
depress ep base excel manag team
manag well difficult situat still believ market need
digest greater magnitud balance-of-year boy revenu weak
well potenti longer durat worri second wave covid
infect winter even covid case hope dissip rapidli next
coupl month social distanc restrict eas time
ep even look coupl year model assum
outsiz averag organ sale growth depress
base hard excit stock remain equal-weight
still prefer overweight rate pepsi-cola similar time ep
much better visibl solid underli top-line growth stori
reinvestment/strategi chang new ceo well mix shift
higher top-line growth margin snack segment pepsi-cola also
defens postur vs covid risk given greater snack home less away
home beverag exposur ko although acknowledg risk
increas post ko result also allow continu invest
pull back ad spend drive forward market share
balanc year revenu growth ko indic april month-to-d volum
global even estim -hsd price/mix impact
package/channel mix shift volum declin impli away home
beverag unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
half revenu mix volum factor modest
volum declin home channel consum deload pantri
call ko indic still earli provid expect path recoveri
highlight still earli phase recoveri recoveri
could u-shap perhap even take v-shape pattern ko indic
see sign sequenti recoveri china march-april return
toward flattish volum recent still take time return normal
still unclear new normal look like would also note
china experienc rapid recoveri covid case like
countri expect top-line profit declin
bottom ko model organ top-line oper profit
declin believ path recoveri still uncertain
time magnitud recoveri expect larg consensu top-line revis
balanc year ep next coupl year
detail call earn call ko discuss impact
busi provid commentari expect phase recoveri ko
seen three phase covid impact busi outbreak
phase govern mandat stay-at-hom order sharp declin
on-premis busi ko global sale includ
gas/conveni gradual reopen phase initi reopen on-
premis locat overal improv consumpt new
normal still earli assess look like look
trend china ko global volum ko saw deterior volum
trend dd y-o-i januari y-o-i februari lock-
measur saw sequenti recoveri march still y-
o-i improv earli april volum closer flat april
date howev ko indic countri might follow trajectori
china could second wave infect social restrict
happen singapor japan cost profit front ko
indic aggress look way lower cost structur
protect top-line ko highlight three area focu market spend
annual spend sale believ
discretionari could reduc covid-environ
reduct worth ep trade dollar opportun adjust
realloc spend discretionari op-ex spend roughli op-ex
cash flow front ko also look way reduc capital-expenditure
proceed commit essenti spend term use cash
ko remain commit dividend rais februari
suspend share repurchas activ sound unlik ko also
indic seen major concern surround bottl partner
liquid perspect final still signific uncertainti
shape recoveri ko express confid emerg covid-
crisi stronger leaner faster aid cultur chang implement
quincey leadership
ep adj ep well ahead consensu
estim flat headlin organ top-line underli basi use
unit case growth headlin organ revenu growth flat y-o-i price/mix
flat concentr sale flat ahead street account consensu
underli organ sale growth use unit case y-o-i vs mse
unit case bp concentr sale rel consensu
revenu came eikon consensu better organ sale
although aid bp varianc concentr shipment vs
expect mean concentr bp unit case
growth expect bp varianc lower fx headwind vs
model gross margin bp eikon consensu bp y-o-i
report basi strong bp y-o-i underli basi ex-
fx/structur lead gross profit beat vs consensu combin
lower expect sg drove oper profit beat
underli oper margin bp y-o-i ex-fx/structur
compar currenc neutral oper profit growth strong y-o-i
lower sg aid lower corpor expens bp
sale time incent compens profit line lower interest
expens cent tailwind vs model free cash flow
y-o-i
guidanc provid given signific volatil impact
ko busi ko provid full updat guidanc
withdrawn march ko provid new updat fx new
top-line impact -msd vs prior -hsd fx impact
oper incom vs prior ko guid underli effect
tax rate unchang guidanc ko estim currenc
headwind top-line oper incom
estim updat net post ep come
reflect beat net lower estim balanc year
ep estim come particularli larg reflect
significantli lower top-line organ sale estim y-o-i vs
prior due weaker expect april result lower assumpt
may/jun expect fy organ sale yoy
pt deriv price-to-earnings multipl line current mega-cap peer
averag offer better near-term visibl despit higher lt growth ko mind
see signic near-term risk ko
on-premis eating/drink busi
sale global us given
gov mandat restaur closur
costa busi msd ko sale also
larg exposur retail store
costa sale could impact
outlook peer strong price
power favor strategi tweak
increas innov cultur shift
becom compani total beverag
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
top-line growth recov
top-line growth recov
lightli top-line growth return msd
ko multipl expand
price-to-earnings close ko multipl
ko deliv lsd top-line growth
ko deliv lsd top-line growth
top-line growth base case assum
sever impact ko on-premis busi
eas appli
price-to-earnings multipl line current
mega-cap peer averag offer better
ko mind
top-line
top-line
impact sever
ko premis busi result
top-line declin volum
valuat contract close
trough multipl recess
bp global price upsid
upsid on-premis sale
bp global price downsid
bp off-premis volum downsid
downsid on-premis sale
convers continu improv
china india
view explan region hierarchi
research highest favor quintil
quicker expect recoveri
power higher product
unfavor fx movement prolong impact
consum behavior tariff emerg
pressur lower expect product
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
good sold
sale
sale bp chang
sale
sale bp chang
less net incom non-controlling interest
net incom attribut sharehold
prepaid expens current asset
trademark indefinit live
account payabl accru expens
loan note payabl
current matur long-term debt
equiti attribut non-control interest
depreci amort
equiti incom loss net dividend
gain sale asset includ bottl interest
net chang oper asset liabil
net provid oper activ
acquisit busi equiti method invest nonmarket secur
purchas invest net
proce dispos busi equiti method invest nonmarket secur
purchas pp
proce dispos pp
net provid use invest activ
issuances/pay debt net
issuanc stock
purchas stock treasuri
net provid use financ activ
effect exchang rate chang
net increas decreas equiv
equiv beg
equiv end
valuat methodolog risk
pt deriv price-to-earnings slightli lt histori reflect
risk upsid
re-acceler flna snack top-line growth improv north america
beverag busi higher invest spend better gm expans favor
commodities/bett price realiz higher cost save restructur
risk downsid
lower return reinvest macro volatil commod fx volatil
greater covid impact greater competit beverag soda tax
